NS
ACAD icon

NBC Securities’s Acadia Pharmaceuticals ACAD Stock Holding History

NBC Securities’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.4K Hold
735
– – ﹤0.01% 1778
2025
Q4 		$19.6K Sell
735
-50
-6% -$1.2K ﹤0.01% 1782
2025
Q3 		$16.8K Sell
785
-50
-6% -$1.18K ﹤0.01% 1835
2025
Q2 		$18K Hold
835
– – ﹤0.01% 1744
2025
Q1 		$13K Buy
+835
New +$15.2K ﹤0.01% 1632
2024
Q4 		– Sell
-685
Closed -$10K – 1247
2024
Q3 		$10K Hold
685
– – ﹤0.01% 1717
2024
Q2 		$11K Buy
685
+175
+34% +$2.82K ﹤0.01% 1635
2024
Q1 		$9K Buy
510
+35
+7% +$867 ﹤0.01% 1719
2023
Q4 		$14K Hold
475
– – ﹤0.01% 1589
2023
Q3 		$9K Buy
+475
New +$12.9K ﹤0.01% 1721

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return